This text is a result of machine translation.
Fosun Pharmaceutical: the new tablet production line of the holding subsidiary passed the GMP compliance inspection
Hong Kong stock kangxinuo biological continued to rise, up more than 10% to HK $79.45.
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Xuelang environment: affected by the epidemic situation, the subsidiary temporarily stopped production and resumed production
Anhui Construction Engineering Group: the holding subsidiary won the bid for three engineering projects, involving a capital of 4.262 billion yuan
2022 China AI Health 30 Report
Zelensky called on the international community to provide funds for Ukraine's reconstruction, which is expected to cost $500 billion
Lihe Kechuang: Lihe Yunji has not carried out experimental verification against monkeypox virus yet
913 companies have been investigated by public funds since the second quarter, and the six top flow fund managers focus on the leaders of subdivided industries
Fosun Pharmaceutical: the holding subsidiary started the phase II clinical study on the treatment of fs-1502 for non-small cell lung cancer
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab
The study data showed that compared to chemotherapy alone, toripalimab in combination with chemotherapy in the first-line treatment of patients with advanced NSCLC without EGFR/ALK mutations could significantly improve the PFS and the OS of patients with a manageable safety profile regardless of PD-L1 expression status.
Sep 20, 2022 03:35 PM
CNMPA Approved World's First Inhaled COVID-19 Vaccine Mist
The liquid form of the vaccine is changed into an aerosol using a nebulizer. It can then be inhaled through the mouth using the nebulizer machine. According to CanSino, the vaccine can effectively induce comprehensive immune protection in response to SARS-CoV-2 after just one breath.
Sep 06, 2022 11:48 AM
Business community: the fundamentals have improved, and PTA may remain upward
Several new funds have actively picked up chips to speed up the pace of position building
The new development bank issued 7 billion yuan of Panda Bonds for infrastructure projects in member countries
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
SARFT Launches Online drama distribution license
Shenglong Co., Ltd.: the business income of supporting products related to new energy vehicles accounts for a small proportion of the company's revenue
On May 11, Ping An of China spent 299 million yuan to buy back 6.6972 million a shares
Nintendo expects profit to fall by 29% this fiscal year and switch sales to 21 million units
Charging Infrastructure on Government Support: A Brighter Future?
Mar 16, 2023 06:03 PM
Robot Policies in Asia
Mar 10, 2023 10:51 AM
Overview of ten Industrial Robot Company in China
Mar 10, 2023 12:59 AM
How Chinese SaaS Firms Survive Globalization
Mar 06, 2023 04:21 PM